Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / *W EXP 12/17/202
-
Total 13F shares
-
4,907,148
-
Share change
-
+4,830,148
-
Total reported value
-
$1,621,737
-
Price per share
-
$0.33
-
Number of holders
-
21
-
Value change
-
+$1,596,307
-
Number of buys
-
18
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q4 2023
As of 31 Dec 2023,
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,907,148 shares.
The largest 10 holders included
D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, Walleye Capital LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., SOROS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Bleichroeder LP, COWEN AND COMPANY, LLC, Sculptor Capital LP, and DAVIDSON KEMPNER CAPITAL MANAGEMENT LP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.